Showing results (1-10 of 117) with videos related to
Sort By:
Pageof 12
Functional Neurology|October 7, 2010
An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's diseaseFabio BlandiniJournal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 5, 2013
Neural and immune mechanisms in the pathogenesis of Parkinson's diseaseFabio BlandiniCNS Drug Reviews|July 12, 2005
Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?Fabio BlandiniExpert Opinion on Pharmacotherapy|August 18, 2020
An update on the use of non-ergot dopamine agonists for the treatment of Parkinson's diseaseSilvia Cerri, Fabio BlandiniJournal of Neuroscience Methods|June 9, 2020
In vivo modeling of prodromal stage of Parkinson's diseaseSilvia Cerri, Fabio BlandiniCurrent Medicinal Chemistry|February 28, 2018
Role of Autophagy in Parkinson's DiseaseSilvia Cerri, Fabio BlandiniExpert Opinion on Investigational Drugs|December 10, 2013
Dopamine receptor agonists for Parkinson's diseaseFabio Blandini, Marie-Therese ArmenteroExpert Opinion on Investigational Drugs|January 12, 2012
New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptorsFabio Blandini, Marie-Therese ArmenteroThe FEBS Journal|January 19, 2012
Animal models of Parkinson's diseaseFabio Blandini, Marie-Therese ArmenteroExpert Opinion on Therapeutic Targets|December 5, 2022
Dyskinesia and Parkinson's disease: animal model, drug targets, and agents in preclinical testingValentina Cesaroni, Fabio Blandini, Silvia CerriPageof 12